Normalization of Lithium-Induced Hypercalcemia and Hyperparathyroidism With Cinacalcet Hydrochloride

American Journal of Kidney Diseases

Volumn 48, Issue 5, 2006, Pages 832-837

  Sloand, James A ^a   Shelly, Mark A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

cinacalcet hydrochloride; familial hypocalciuric hypercalcemia; hypercalcemia; hyperparathyroidism; hypocalciuria; Lithium carbonate; long term lithium therapy; loop of Henle; parathyroid hormone

Indexed keywords

CINACALCET; LITHIUM CARBONATE;

ADULT; AGED; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CASE REPORT; CHRONIC KIDNEY DISEASE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHYSICAL EXAMINATION; URINARY EXCRETION;

AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; LITHIUM CARBONATE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE;

EID: 33750090694     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.07.019     Document Type: Article

References (25)

1. Goodwin F.K. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 63 suppl 10 (2002) S5-S12
2. Presne C., Fakhouri F., Noel L.-H., et al. Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int 64 (2003) 585-592
3. Boton R., Gaviria M., and Batile D.C. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10 (1987) 329-345
4. McHenry C.R., and Lee K. Lithium therapy and disorders of the parathyroid glands. Endocr Pract 2 (1996) 103-109
5. Awad S.S., Miskulin J., and Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27 (2003) 486-488
6. Bendz H., Sjodin I., Toss G., et al. Hyperparathyroidism and long term lithium therapy-A cross-sectional study and the effect of lithium withdrawal. J Intern Med 240 (1996) 357-365
7. Pieri-Balandraud N., Hugueny P., Henry J.F., Tournebise H., and Dupont C. Hyperparathyroidism induced by lithium: A new case. Rev Med Interne 22 (2001) 460-464
8. Wolf M.E., Moffat M., Mosnaim J., and Dempsey S. Lithium therapy, hypercalcemia and hyperparathyroidism. Am J Ther 4 (1997) 323-325
9. Wolf M.E., Ranade V., Molnar J., Somberg J., and Mosnaim A.D. Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol 20 (2000) 260-264
10. Nemeth E.F., Steffey M.E., Hammerland L.G., et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A 95 (1998) 4040-4045
11. Peacock M., Bilezikian J.P., Klassen P.S., Guo M.D., Turner S.A., and Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90 (2005) 135-141
12. Quarles L.D., Sherrard D.J., Adler S., et al. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14 (2003) 575-583
13. Levey A., Bosch J., Lewis J., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130 (1999) 461-470
14. Garfinkel P.E., Ezrin C., and Stancer H.C. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2 (1973) 331-332
15. Mallette L.E., and Eichhorn E. Effects of lithium carbonate on human calcium metabolism. Arch Intern Med 146 (1986) 770-776
16. Birnbaum J., Klandorf H., Giulano A., and Van Herle A. Lithium stimulates the release of human parathyroid hormone in vitro. J Clin Endocrinol Metab 66 (1988) 1187-1191
17. Lions C., Precloux P., Burckard E., Soubirou J.L., and Escarment J. Important hypercalcaemia due to hyperparathyroidism induced by lithium. Ann Fr Anesth Reanim 24 (2005) 270-273
18. Brochier T., Adnet-Kessous J., Barillot M., and Pascalis J.G. Hyperparathyroidism with lithium. Encephale 20 (1994) 339-349
19. Brown E.M. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am 29 (2000) 503-522
20. Poliak M.R., Brown E.M., Chou Y.H., et al. Mutations in the human calcium-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 (1993) 1297-1303
21. Hershfinkel M., Moran A., Grossman N., and Sekler I. A zinc-sensing receptor triggers the release of intracellular calcium and regulated ion transport. Proc Natl Acad Sci 98 (2001) 11749-11754
22. Haven C.J., Howell V.M., Eilers P.H., et al. Gene expression of parathyroid tumors: Molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64 (2004) 7405-7411
23. Ho C., Conner D.A., Pollak M.R., et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11 (1995) 389-394
24. 3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 116 (2006) 1668-1674
25. Poon G. Cinacalcet hydrochloride (Sensipar). Proc Baylor Univ Med Center 18 (2005) 181-184